ABBOTT AXSYM TROPONIN-I ADV— 510(k) K041811

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K041811 for ABBOTT AXSYM TROPONIN-I ADV, Substantially Equivalent on 2004-09-10. Applicant: Abbott Laboratories.

Clearance details

Applicant: Abbott Laboratories
Product code: Code MMI
Advisory panel: Clinical Chemistry
Date received: 2004-07-06
Decision date: 2004-09-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code MMI

product code MMI

Injury: 172
Malfunction: 3,762
Total: 3,934

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.